Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C031903 |
1-UFT protocol |
FUCA1 protein results in increased susceptibility to 1-UFT protocol | increases response to substance | 16734730
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of FUCA1 mRNA | affects expression | 16483693
|
C006632 |
arsenic trioxide |
arsenic trioxide results in increased expression of FUCA1 mRNA | increases expression | 20458559
|
D001564 |
Benzo(a)pyrene |
AHR protein affects the reaction [Benzo(a)pyrene results in increased expression of FUCA1 mRNA] | affects reaction|increases expression | 20064835
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of FUCA1 mRNA | increases expression | 20064835
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of FUCA1 mRNA | increases expression | 20382639
|
C110904 |
capecitabine |
FUCA1 protein results in increased susceptibility to capecitabine | increases response to substance | 16734730
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride affects the expression of FUCA1 mRNA | affects expression | 17484886
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of FUCA1 mRNA | decreases expression | 20106945
|
C025034 |
doxifluridine |
FUCA1 protein results in increased susceptibility to doxifluridine | increases response to substance | 16734730
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of FUCA1 mRNA | affects expression | 17555576
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of FUCA1 mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FUCA1 mRNA | affects cotreatment|increases expression | 17942748
|
D008767 |
Methylmercury Compounds |
Methylmercury Compounds results in increased expression of FUCA1 mRNA | increases expression | 16966085
|
C029938 |
nickel sulfate |
nickel sulfate results in decreased expression of FUCA1 mRNA | decreases expression | 16780908
|
C079198 |
S 1 (combination) |
FUCA1 protein results in increased susceptibility to S 1 (combination) | increases response to substance | 16734730
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of FUCA1 mRNA | affects expression | 17555576
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FUCA1 mRNA | affects cotreatment|increases expression | 17942748
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of FUCA1 mRNA | increases expression | 19465110 17942748
|
D019772 |
Topotecan |
FUCA1 protein affects the susceptibility to Topotecan | affects response to substance | 16217747
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.58 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.87 | 15322242 14514962 11752688 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.58 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.97 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
nickel sulfate |
4.31 | 16100012 12718980 11954676 19131640 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
7.03 | 11798837 19825857 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
7.03 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
7.03 | 14692618 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.65 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.40 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.95 | 11748828 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.09 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.48 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.66 | 15885639 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
8.98 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.98 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.82 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.76 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.00 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
capecitabine |
2.00 | 18473752 12972520 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
2.00 | 19103187 20544844 17242785 20135344 19288272 18997820 19289846 20065188 19066611 15668708 19244106 19189210 18425577 16202921 20859285 19011961 19059307 18821012 18984771 17893378 20005174 19155303 16818667 15565566 17440819 19221464 19200415 18629630 21152245 19115204 16273361 18855134 16873071 19189212 21138602 18351453 20390343 19084267 19487384 19142967 19410462 18815881 17049068 11161223 17261762 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.00 | 20435547 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.34 | 11589617 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.79 | 16227642 18705752 15673190 16192424 15700767 16011737 15721981 16050911 10355542 16124888 3786805 16097048 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.80 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.52 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
4.61 | 11135700 16217749 15553829 14691202 15073043 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
4.61 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
4.61 | 16924424 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
S 1 (combination) |
4.07 | 18212800 18347146 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.90 | 19014326 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
4.12 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
5.14 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
S 1 (combination) |
5.14 | 15984520 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.62 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.37 | 18850075 18670907 16120746 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
6.56 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
6.56 | 12371664 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.16 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.78 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
7.78 | 16105132 17110522 16919318 15861022 17681005 17333356 11677210 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.10 | 12621046 8697196 16354765 15340226 15668235 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
3.03 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
capecitabine |
3.03 | 18473752 18448328 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.06 | 17141729 14669216 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
4.19 | 12609071 |
MESH:D003329 |
Coronary Vasospasm |
|
capecitabine |
5.82 | 17465463 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
2.47 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.47 | 15322242 10048152 20055451 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
4.10 | 15213294 |
MESH:D003704 |
Dementia |
|
Methylmercury Compounds |
5.00 | 16140633 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.38 | 19031437 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
nickel sulfate |
3.69 | 16823706 16780908 11298694 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.67 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
3.48 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
3.73 | 19336974 2869522 3732212 15027814 16177239 4309450 7120509 19085960 6623471 16227642 6884620 7440962 11566570 15968718 15998439 9327722 7179309 21278145 3786805 10915739 10092053 17522070 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.73 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.76 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.38 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.93 | 16714409 15322242 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
8.98 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
8.98 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
3.05 | 19155303 16202921 17893378 20544844 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.02 | 10568697 9294722 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7.22 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
7.22 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
7.22 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.01 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
24.72 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
24.72 | 12795759 17595544 12631006 61145 16239168 19224547 15959796 16045604 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
24.72 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
24.72 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
24.72 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.24 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.47 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.55 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.20 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
14.80 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
14.80 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
14.80 | 20067830 |
MESH:D005645 |
Fucosidosis |
marker/mechanism |
|
| |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
11.82 | 16904648 |
MESH:D005706 |
Gallbladder Neoplasms |
|
S 1 (combination) |
11.82 | 19093184 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.24 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.62 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
S 1 (combination) |
4.75 | 18607998 15984520 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.45 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.45 | 11294989 10048152 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.44 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.34 | 11000095 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.60 | 19900420 19110552 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.91 | 16120746 15340226 12621046 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.08 | 16354765 16959395 15340226 18606429 8697196 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.55 | 16899240 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
4.95 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.95 | 18850075 18670907 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
4.10 | 15338365 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.82 | 16945680 16569931 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.47 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.49 | 17937319 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
4.89 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
4.89 | 12878042 12200463 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.34 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.47 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.34 | 8314463 10903974 18776723 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
7.30 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
7.30 | 18625569 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
2.83 | 15070760 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.80 | 17077332 12560223 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.33 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.43 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
3.76 | 19077051 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
2.14 | 20471514 16968895 16467208 19850784 17050201 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
3.22 | 12712474 15336539 17649720 16331271 17712046 15748426 9834237 19225113 16112521 12018890 19642359 16966277 16891316 16330433 11468182 15622746 17107899 19075265 15213294 11161223 17217047 17869043 16823087 12679006 19035177 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.36 | 16882451 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.16 | 15342952 17567588 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
2.81 | 21278145 11903743 17334410 11408273 17157831 16943688 16239168 17174718 16221502 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
3.44 | 13678700 12389079 15818738 12649538 18412020 17805973 12546737 18054572 17557913 16248980 18205269 12632514 10355542 15338365 17721639 18210741 18279442 12445418 18395914 17922224 12898905 17708605 18472332 17714472 12667390 16015684 18277467 15673190 16116963 18376398 18339082 18251166 18263696 15931870 17525996 15370692 18429990 14512876 15876570 17823541 12586293 12666154 12958196 15730626 16097048 17761835 18187930 14716496 14724832 18006644 18472094 14620537 14748882 15925388 18481824 16638106 15362042 17698563 18705752 18156304 16033810 15650968 18166357 15996030 17869086 15959796 12609069 11481614 15123356 17944888 16192424 14716833 18418968 18317297 16136751 20821823 15052691 12741479 12445421 18395095 15893842 16027843 17481882 17976157 17766677 17631135 17565644 15057751 18420326 12632512 17900296 17640975 16011737 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
3.44 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.44 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
2.08 | 17285989 16964402 16246199 15720792 15830285 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
4.18 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.69 | 16899240 14706259 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
14.25 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
14.25 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
14.25 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
14.25 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
14.25 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
9.82 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
9.82 | 15583823 12014681 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
9.82 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.35 | 15213294 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
4.83 | 11798837 19825857 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
4.83 | 20135361 18569708 20064080 18520028 17053015 20464547 6695378 18816296 20869020 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
4.83 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
4.83 | 19555203 11884234 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.78 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
2.62 | 14580682 19196722 11731420 16827153 19196723 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.58 | 19453300 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
1.88 | 19393235 12393984 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.20 | 15990972 |
MESH:D008569 |
Memory Disorders |
|
Methylmercury Compounds |
4.92 | 18436314 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.82 | 16801185 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.19 | 16381670 |
MESH:D009069 |
Movement Disorders |
|
Methylmercury Compounds |
5.33 | 18436314 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
3.11 | 15949261 19417148 19549372 11468182 14977855 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.70 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
3.14 | 16105982 16882451 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.02 | 12213967 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
3.97 | 16624393 |
MESH:D009362 |
Neoplasm Metastasis |
|
capecitabine |
6.31 | 12972520 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
6.31 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.52 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
5.55 | 11141357 |
MESH:D009369 |
Neoplasms |
|
capecitabine |
5.55 | 16374040 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.03 | 19200415 19189210 19196722 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.47 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.29 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.22 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
3.12 | 10525206 |
MESH:D009447 |
Neuroblastoma |
|
Topotecan |
3.85 | 15176712 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
2.41 | 16624393 19769630 12452020 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
2.52 | 15580305 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.69 | 11578682 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
4.17 | 19927285 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.28 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.57 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.22 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Methylmercury Compounds |
9.95 | 18436314 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.95 | 11118676 11896295 11222880 11399792 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
2.53 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.53 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.53 | 15067354 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.33 | 15861022 16919318 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.23 | 16882103 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.85 | 18990726 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
3.97 | 16646077 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
5.48 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.48 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
11.66 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
11.66 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
4.06 | 19457130 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
3.55 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
3.55 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
S 1 (combination) |
3.55 | 18506536 16557585 18553229 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.63 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.15 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.93 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
3.09 | 19014326 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.98 | 15213294 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
8.31 | 12845720 20435036 11780464 12973940 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
8.31 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
8.31 | 16712894 17572228 8653321 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.31 | 14692618 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.01 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.62 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.54 | 14671159 15869587 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.28 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.47 | 17120751 |